HilleVax, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 36.96 million compared to USD 21.19 million a year ago. Basic loss per share from continuing operations was USD 0.78 compared to USD 0.56 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.13 USD | -3.74% | -5.47% | -18.19% |
09/05 | HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05/04 | Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.19% | 65Cr | |
+29.03% | 4.82TCr | |
-0.10% | 4.17TCr | |
+43.45% | 4.1TCr | |
-5.26% | 2.88TCr | |
+11.48% | 2.56TCr | |
-22.74% | 1.9TCr | |
+9.06% | 1.29TCr | |
+30.01% | 1.2TCr | |
-1.51% | 1.18TCr |
- Stock Market
- Equities
- HLVX Stock
- News HilleVax, Inc.
- HilleVax, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023